The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.
Among the Ebola viruses most species cause severe hemorrhagic fever in humans; however, Reston ebolavirus (REBOV) has not been associated with human disease despite numerous documented infections. While the molecular basis for this difference remains unclear, in vitro evidence has suggested a role f...
Guardado en:
Autores principales: | Allison Groseth, Andrea Marzi, Thomas Hoenen, Astrid Herwig, Don Gardner, Stephan Becker, Hideki Ebihara, Heinz Feldmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/835ee4875e3c44228c2249d9b9ebd927 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
por: Wakako Furuyama, et al.
Publicado: (2021) -
Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
por: Logan Banadyga, et al.
Publicado: (2017) -
An upstream open reading frame modulates ebola virus polymerase translation and virus replication.
por: Reed S Shabman, et al.
Publicado: (2013) -
Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.
por: Masfique Mehedi, et al.
Publicado: (2013) -
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Punya Shrivastava-Ranjan, et al.
Publicado: (2018)